
Biotech Business - October 19, 2015
Progenics announces offer to acquire EXINI
Progenics Pharmaceuticals has offered to acquire Swedish company EXINI Diagnostics through a public offer to the shareholders of EXINI. EXINI is headquartered in Lund, Sweden, and is listed on Nasdaq First North, Stockholm. The company develops software solutions for medical decision support based on advanced image analysis. EXINI has demonstrated experience in the successful development […]